Royalty Pharma 

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$609,291
$578,665
$568,247
$593,641
Gross Profit
609,291
578,665
568,247
593,641
EBITDA
525,052
159,303
498,694
400,112
EBIT
523,775
209,799
534,182
361,514
Net Income
288,217
30,176
238,349
208,214
Net Change In Cash
609,291
578,665
568,247
593,641
Free Cash Flow
640,741
426,972
596,076
742,525
Cash
938,944
631,908
1,087,720
929,026
Basic Shares
559,611
562,000
578,000
589,000

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$2,263,576
$2,354,554
$2,237,215
$2,289,463
Gross Profit
2,263,576
2,354,554
2,237,215
2,289,463
EBITDA
1,556,325
1,887,275
423,695
1,430,339
EBIT
1,292,444
1,492,150
418,025
1,407,343
Net Income
858,983
1,134,834
42,832
619,728
Net Change In Cash
2,263,576
2,354,554
2,237,215
2,289,463
Cost of Revenue
169,703
532,368
Free Cash Flow
2,768,986
2,987,802
4,185,132
2,018,059
Cash
929,026
477,010
1,710,751
1,541,048
Basic Shares
594,000
602,900
437,972
414,802

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$1.17
2025-06-30
$1.14
2025-03-31
$1.06